about
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs AntagonistsPeptides Interfering 3A Protein Dimerization Decrease FMDV MultiplicationCyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with DiclofenacEfficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies.Solid-phase peptide synthesis (SPPS), C-terminal vs. side-chain anchoring: a reality or a myth.Promises and pitfalls of intracellular delivery of proteins.Peptide-mediated delivery: an overview of pathways for efficient internalization.Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.Prospect and progress of gene therapy in treating atherosclerosis.Strategies to stabilize cell penetrating peptides for in vivo applications.Conjugation of photosensitisers to antimicrobial peptides increases the efficiency of photodynamic therapy in cancer cells.A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.Enhanced serum proteolysis resistance of cell-penetrating peptides.Nuclease resistant oligonucleotides with cell penetrating properties.The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.Type II CRISPR/Cas9 approach in the oncological therapy.Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growthCell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus.Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation.
P2860
Q33657689-D476D835-A6FC-43E8-9FEF-BAEF4486DE40Q35634594-10FCFB56-1038-4EE8-9898-BB01E4AF0637Q35822523-EB36E731-4A5A-4E38-8D98-0DF25BABB617Q36109341-DCC79C16-7FA2-400E-81C6-24D419D434B0Q37580169-E187083F-708B-46BB-9D56-3CDE6031468FQ38198590-0B110566-043F-4DB1-B0E7-723AD40129E3Q38207510-53A0AFDD-9227-4463-9138-E20760A483E1Q38240926-B966C3AF-4515-4E67-A376-D3716D8C5C3BQ38285852-00124493-1067-4CA7-89B6-0EF977C269D1Q38563691-1A1A85F3-714A-439C-97D9-B142C7423287Q38578275-BB4E9440-493C-48AD-812A-88DDC4E352C8Q38602460-A083BB36-F541-415C-80AC-DE9083FEA952Q38870536-43A6A6F6-24DB-40DC-9AE5-8559DF9B6788Q38889775-32551D53-DEDB-4FBA-9FE4-9B2B7F797A09Q38908688-EBDAFD61-A034-4C31-944F-4083FE867A49Q38911554-84BEF754-72BB-42D2-B208-200C800F740EQ38996957-7D363FFD-8A74-4435-8443-39DA1813B34DQ39376221-AFD7A8E4-A84E-43CD-95CE-C5E3F69F5D37Q39529516-D972BA40-25A9-4038-80B3-AAADD2CF4419Q40808308-EBC6599B-D1A2-4289-9CFD-0ED2855EB929Q41710814-8DE97298-6D98-4659-8C77-C03616C177A4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic potential of cell-penetrating peptides.
@en
type
label
Therapeutic potential of cell-penetrating peptides.
@en
prefLabel
Therapeutic potential of cell-penetrating peptides.
@en
P2860
P356
P1433
P1476
Therapeutic potential of cell-penetrating peptides
@en
P2093
Kalle Pärn
P2860
P304
P356
10.4155/TDE.13.22
P577
2013-05-01T00:00:00Z